We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

The Link Between Cytokine Levels and Loss of Olfaction in Chronic Rhinosinusitis—Reply ONLINE FIRST

Rodney J. Schlosser, MD1; Jennifer K. Mulligan, PhD1; Zachary M. Soler, MD, MSc1
[+] Author Affiliations
1Medical University of South Carolina, Charleston
JAMA Otolaryngol Head Neck Surg. Published online September 01, 2016. doi:10.1001/jamaoto.2016.2427
Text Size: A A A
Published online


In Reply We would like to thank Mr Chidambaram and Mr Goh for their interest in our recent article.1 They commend our study for using validated olfactory metrics, but raise a number of concerns regarding the labile nature of cytokines. Their first point is that the study was conducted on the grounds of ex vivo experiments and animal models and it is questionable that inflammatory cytokines display a consistent profile in chronic rhinosinusitis (CRS). While it is very likely that cytokine and biomarker levels vary throughout the dynamic course of CRS, our patients were sampled when they were most likely to demonstrate the most severe states of inflammation—off systemic steroids and presenting for treatment. Furthermore, our studies were actually based on numerous in vivo human studies that are pursuing local sampling of inflammatory cytokines as a means of classifying CRS. For example, recent work has shown that CRS patients can be clustered based on local tissue cytokine levels that may represent specific endotypes.2 While there are certainly going to be fluctuations from patient to patient or during various time points in the course of CRS, there are some consistent findings across studies, such as elevated T helper 2 cytokines in patients with nasal polyps, and these may allow prognostic and/or mechanistic insights. We have previously demonstrated that mucus cytokines typically correlate with tissue levels3; thus, while mucus cytokines in CRS certainly vary, sampling them appears to be a reasonable approach to further understanding this inflammatory process.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





September 1, 2016
Swathikan Chidambaram, BSc; En Lin Goh, BSc
1School of Medicine, Imperial College London, United Kingdom
JAMA Otolaryngol Head Neck Surg. Published online September 01, 2016.;():. doi:10.1001/jamaoto.2016.2424.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...